Immediate Impact
60 hit
Citing Papers
A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX
2025 Hit
Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy
2025 Hit
Works of Michael N. Cohen being referenced
Racial, Ethnic, and Gender Disparities in Diabetic Macular Edema Clinical Trials
2022
APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration
2020
Author Peers
Peers are selected by citation overlap in the author's most active subfields. citations · hero ref
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Michael N. Cohen | 200 | 130 | 90 | 43 | 36 | 45 | 388 | |
| Rinat M. Zainullin | 227 1.1× | 166 1.3× | 13 0.1× | 31 0.7× | 10 0.3× | 45 | 421 | |
| Giancarlo Sborgia | 197 1.0× | 179 1.4× | 37 0.4× | 33 0.8× | 11 0.3× | 57 | 386 | |
| J. Katsimpris | 332 1.7× | 200 1.5× | 24 0.3× | 38 0.9× | 24 0.7× | 37 | 420 | |
| Fabio Cruciani | 139 0.7× | 77 0.6× | 55 0.6× | 41 1.0× | 45 1.3× | 41 | 433 | |
| Peyman Roomizadeh | 52 0.3× | 115 0.9× | 27 0.3× | 14 0.3× | 132 3.7× | 21 | 380 | |
| Mingxu Wang | 144 0.7× | 94 0.7× | 15 0.2× | 85 2.0× | 30 0.8× | 32 | 399 | |
| Dilya F. Yakupova | 195 1.0× | 144 1.1× | 15 0.2× | 17 0.4× | 8 0.2× | 23 | 352 | |
| Turgay Ulaş | 34 0.2× | 45 0.3× | 38 0.4× | 35 0.8× | 63 1.8× | 37 | 390 | |
| Zeki Bayraktar | 107 0.5× | 57 0.4× | 57 0.6× | 49 1.1× | 68 1.9× | 31 | 387 | |
| Qiuyue Tian | 55 0.3× | 62 0.5× | 16 0.2× | 86 2.0× | 32 0.9× | 38 | 407 |
All Works
Loading papers...